Microbiota and human allergic diseases: the company we keep

Environmental, maternal and early life microbial/immune networks program human developmental trajectories and health outcomes and strongly modify allergic disease risk. The effects of environmental microbiota are illustrated by the ‘farm effect’ (the protection against asthma and allergy conferred b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in immunology 2021-10, Vol.72, p.215-220
1. Verfasser: Vercelli, Donata
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 220
container_issue
container_start_page 215
container_title Current opinion in immunology
container_volume 72
creator Vercelli, Donata
description Environmental, maternal and early life microbial/immune networks program human developmental trajectories and health outcomes and strongly modify allergic disease risk. The effects of environmental microbiota are illustrated by the ‘farm effect’ (the protection against asthma and allergy conferred by growing up on a traditional farm) and other natural experiments in populations exposed to microbe-rich environments. The role of gut microbiome maturation in the asthma/allergy trajectory is demonstrated by the most recent farm studies, which identified microbial metabolites specifically associated with asthma protection, and studies in other cohorts, which defined dynamic microbial community profiles associated with allergic disease phenotypes. Current and future studies in germ-free mice associated with gut microbiota from human disease states are providing novel mechanistic insights into the role of microbiota in shaping immune function and allergic disease susceptibility.
doi_str_mv 10.1016/j.coi.2021.06.002
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8578191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0952791521000704</els_id><sourcerecordid>2546601606</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-a3d7d657612efa599ec3f902dab9aa01b1bb7589c5525369b2462f3f7806ac0f3</originalsourceid><addsrcrecordid>eNp1kE1P3DAQhi1UBFvgB_RS5dhL0rGztuMiVUKrFpBAXOBsTZwJ620-tnZCxb_Hq6WoPXCaw7zvM6OHsU8cCg5cfd0UbvSFAMELUAWAOGALXmmTQ6nFB7YAI0WuDZfH7GOMGwCQsoQjdlwueSWE5gt2futdGGs_Tpjh0GTrucchw66j8Ohd1vhIGCl-y6Y1ZW7stzg8Z38o-0W0PWWHLXaRzl7nCXv4-eN-dZXf3F1ery5ucreUfMqxbHSjpFZcUIvSGHJla0A0WBtE4DWvay0r46QUslSmFksl2rLVFSh00JYn7Pueu53rnhpHwxSws9vgewzPdkRv_98Mfm0fxydbSV1xwxPgyysgjL9nipPtfXTUdTjQOEcr5FKpJBRUivJ9NFmJMVD7doaD3Um3G5uk2510C8om6anz-d__3hp_LafA-T5AydKTp2Cj8zQ4anwgN9kmAd_HvwBdNpJk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2546601606</pqid></control><display><type>article</type><title>Microbiota and human allergic diseases: the company we keep</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Vercelli, Donata</creator><creatorcontrib>Vercelli, Donata</creatorcontrib><description>Environmental, maternal and early life microbial/immune networks program human developmental trajectories and health outcomes and strongly modify allergic disease risk. The effects of environmental microbiota are illustrated by the ‘farm effect’ (the protection against asthma and allergy conferred by growing up on a traditional farm) and other natural experiments in populations exposed to microbe-rich environments. The role of gut microbiome maturation in the asthma/allergy trajectory is demonstrated by the most recent farm studies, which identified microbial metabolites specifically associated with asthma protection, and studies in other cohorts, which defined dynamic microbial community profiles associated with allergic disease phenotypes. Current and future studies in germ-free mice associated with gut microbiota from human disease states are providing novel mechanistic insights into the role of microbiota in shaping immune function and allergic disease susceptibility.</description><identifier>ISSN: 0952-7915</identifier><identifier>EISSN: 1879-0372</identifier><identifier>DOI: 10.1016/j.coi.2021.06.002</identifier><identifier>PMID: 34182271</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Age Factors ; Disease Susceptibility ; Environmental Exposure ; Host Microbial Interactions - immunology ; Humans ; Hypersensitivity - diagnosis ; Hypersensitivity - etiology ; Hypersensitivity - metabolism ; Microbiota - immunology</subject><ispartof>Current opinion in immunology, 2021-10, Vol.72, p.215-220</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-a3d7d657612efa599ec3f902dab9aa01b1bb7589c5525369b2462f3f7806ac0f3</citedby><cites>FETCH-LOGICAL-c451t-a3d7d657612efa599ec3f902dab9aa01b1bb7589c5525369b2462f3f7806ac0f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.coi.2021.06.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34182271$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vercelli, Donata</creatorcontrib><title>Microbiota and human allergic diseases: the company we keep</title><title>Current opinion in immunology</title><addtitle>Curr Opin Immunol</addtitle><description>Environmental, maternal and early life microbial/immune networks program human developmental trajectories and health outcomes and strongly modify allergic disease risk. The effects of environmental microbiota are illustrated by the ‘farm effect’ (the protection against asthma and allergy conferred by growing up on a traditional farm) and other natural experiments in populations exposed to microbe-rich environments. The role of gut microbiome maturation in the asthma/allergy trajectory is demonstrated by the most recent farm studies, which identified microbial metabolites specifically associated with asthma protection, and studies in other cohorts, which defined dynamic microbial community profiles associated with allergic disease phenotypes. Current and future studies in germ-free mice associated with gut microbiota from human disease states are providing novel mechanistic insights into the role of microbiota in shaping immune function and allergic disease susceptibility.</description><subject>Age Factors</subject><subject>Disease Susceptibility</subject><subject>Environmental Exposure</subject><subject>Host Microbial Interactions - immunology</subject><subject>Humans</subject><subject>Hypersensitivity - diagnosis</subject><subject>Hypersensitivity - etiology</subject><subject>Hypersensitivity - metabolism</subject><subject>Microbiota - immunology</subject><issn>0952-7915</issn><issn>1879-0372</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1P3DAQhi1UBFvgB_RS5dhL0rGztuMiVUKrFpBAXOBsTZwJ620-tnZCxb_Hq6WoPXCaw7zvM6OHsU8cCg5cfd0UbvSFAMELUAWAOGALXmmTQ6nFB7YAI0WuDZfH7GOMGwCQsoQjdlwueSWE5gt2futdGGs_Tpjh0GTrucchw66j8Ohd1vhIGCl-y6Y1ZW7stzg8Z38o-0W0PWWHLXaRzl7nCXv4-eN-dZXf3F1ery5ucreUfMqxbHSjpFZcUIvSGHJla0A0WBtE4DWvay0r46QUslSmFksl2rLVFSh00JYn7Pueu53rnhpHwxSws9vgewzPdkRv_98Mfm0fxydbSV1xwxPgyysgjL9nipPtfXTUdTjQOEcr5FKpJBRUivJ9NFmJMVD7doaD3Um3G5uk2510C8om6anz-d__3hp_LafA-T5AydKTp2Cj8zQ4anwgN9kmAd_HvwBdNpJk</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Vercelli, Donata</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211001</creationdate><title>Microbiota and human allergic diseases: the company we keep</title><author>Vercelli, Donata</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-a3d7d657612efa599ec3f902dab9aa01b1bb7589c5525369b2462f3f7806ac0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age Factors</topic><topic>Disease Susceptibility</topic><topic>Environmental Exposure</topic><topic>Host Microbial Interactions - immunology</topic><topic>Humans</topic><topic>Hypersensitivity - diagnosis</topic><topic>Hypersensitivity - etiology</topic><topic>Hypersensitivity - metabolism</topic><topic>Microbiota - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vercelli, Donata</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current opinion in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vercelli, Donata</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microbiota and human allergic diseases: the company we keep</atitle><jtitle>Current opinion in immunology</jtitle><addtitle>Curr Opin Immunol</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>72</volume><spage>215</spage><epage>220</epage><pages>215-220</pages><issn>0952-7915</issn><eissn>1879-0372</eissn><abstract>Environmental, maternal and early life microbial/immune networks program human developmental trajectories and health outcomes and strongly modify allergic disease risk. The effects of environmental microbiota are illustrated by the ‘farm effect’ (the protection against asthma and allergy conferred by growing up on a traditional farm) and other natural experiments in populations exposed to microbe-rich environments. The role of gut microbiome maturation in the asthma/allergy trajectory is demonstrated by the most recent farm studies, which identified microbial metabolites specifically associated with asthma protection, and studies in other cohorts, which defined dynamic microbial community profiles associated with allergic disease phenotypes. Current and future studies in germ-free mice associated with gut microbiota from human disease states are providing novel mechanistic insights into the role of microbiota in shaping immune function and allergic disease susceptibility.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34182271</pmid><doi>10.1016/j.coi.2021.06.002</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0952-7915
ispartof Current opinion in immunology, 2021-10, Vol.72, p.215-220
issn 0952-7915
1879-0372
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8578191
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Age Factors
Disease Susceptibility
Environmental Exposure
Host Microbial Interactions - immunology
Humans
Hypersensitivity - diagnosis
Hypersensitivity - etiology
Hypersensitivity - metabolism
Microbiota - immunology
title Microbiota and human allergic diseases: the company we keep
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A19%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microbiota%20and%20human%20allergic%20diseases:%20the%20company%20we%20keep&rft.jtitle=Current%20opinion%20in%20immunology&rft.au=Vercelli,%20Donata&rft.date=2021-10-01&rft.volume=72&rft.spage=215&rft.epage=220&rft.pages=215-220&rft.issn=0952-7915&rft.eissn=1879-0372&rft_id=info:doi/10.1016/j.coi.2021.06.002&rft_dat=%3Cproquest_pubme%3E2546601606%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2546601606&rft_id=info:pmid/34182271&rft_els_id=S0952791521000704&rfr_iscdi=true